Xiaohui He

USPTO Granted Patents = 18 (Patent Applications = 5)

EPO Patents = 2 (Patent Applications = 6)

Average Co-Inventor Count = 6.6

ph-index = 6

Forward Citations = 118(Granted Patents)

Company Filing History:

Wisys Technology Foundation, Inc.

patents

1 out of 1

Irm Llc, a Delaware Limited Liability Company

Bristol-myers Squibb Compnay

patents

6. 1 out of 832,680

Other

patents

Years Active: 2006-2019

Loading Chart...

18 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. RE47475 - Selective agents for pain suppression (2019-07-01),

2. 8859574 - Compounds and compositions as kinase inhibitors (2014-10-14),

3. 8722692 - Compounds and compositions as Syk kinase inhibitors (2014-05-13),

4. 8722691 - Azolopyrimidines as inhibitors of cannabinoid 1 activity (2014-05-13),

5. 8519129 - Pyrimidine derivatives as kinase inhibitors (2013-08-27),

6. 8445505 - Pyrimidine derivatives as kinase inhibitors (2013-05-21),

7. 8440681 - 2-biphenylamino-4-aminopyrimidine derivatives as kinase inhibitors (2013-05-14),

8. 8431607 - Compounds and compositions as inhibitors of cannabinoid receptor 1 activity (2013-04-30),

9. 8362050 - Compounds and methods for modulating G protein-coupled receptors (2013-01-29),

10. 8158634 - Compounds and compositions as inhibitors of cannabinoid receptor 1 activity (2012-04-17),

11. 7968557 - Substituted pyrrolo[2,3-2]pyrimidines as protein kinase inhibitors (2011-06-28),

12. 7601742 - Pyrrolidones with anti-HIV activity (2009-10-13),

13. 7579363 - Bicyclic compounds and compositions as PDF inhibitors (2009-08-25),

14. 7495016 - Pyrrolidones with anti-HIV activity (2009-02-24),

15. 7253164 - Bicyclic compounds and compositions as PDF inhibitors (2007-08-07),

Title: Unveiling the Inventive Genius of Xiaohui He

Introduction:

Xiaohui He, a prolific inventor based in San Diego, CA, has made significant contributions to the field of pharmaceuticals with a total of 18 patents to his name. His groundbreaking work has revolutionized treatments for a range of conditions, focusing on pain suppression and kinase inhibition.

Latest Patents:

1. Selective agents for pain suppression: Xiaohui He's latest patent introduces innovative methods and pharmaceutical compositions designed to suppress, alleviate, and prevent chronic pain associated with inflammatory diseases and neuropathic insults. By utilizing benzodiazepine derivatives, the patent aims to mitigate neuropathic, migraine-related, and inflammatory pain while minimizing sedative and ataxic side effects.

2. Compounds and compositions as kinase inhibitors: In another patent, Xiaohui He explores the development of novel pyrimidine derivatives and pharmaceutical compositions for the treatment of conditions responsive to the inhibition of insulin-like growth factor (IGF-1R) or anaplastic lymphoma kinase (ALK).

Career Highlights:

Xiaohui He has held pivotal roles in renowned companies such as Irm LLC and Wisys Technology Foundation, Inc., where his innovative spirit and scientific expertise have driven advancements in pharmaceutical research and development. His dedication to exploring novel therapies has garnered him a reputation as a trailblazer in the industry.

Collaborations:

Throughout his career, Xiaohui He has collaborated closely with esteemed peers such as Kunyong Yang and Yun He, fostering a rich environment for idea exchange and collective innovation. His collaborative efforts have not only enhanced his own inventions but have also contributed to the broader scientific community.

Conclusion:

In conclusion, Xiaohui He stands as a testament to the power of ingenuity and perseverance in the realm of pharmaceutical innovation. His patents showcase a deep commitment to improving patient outcomes and advancing medical science, solidifying his legacy as a pioneering inventor in the field.

This text is generated by artificial intelligence and may not be accurate.